Clinical Scorecard: Pathology Blueprint Backs In Vitro Diagnostics

At a Glance

Key Highlights

• IVDs influence around 70% of clinical decisions while accounting for less than 1% of NHS spending.
• Community-based point-of-care testing can significantly reduce test turnaround times.
• Self-sampling for HPV could improve cervical cancer screening participation.
• AI-enabled digital pathology can help manage laboratory workloads and improve access to expertise.
• Recommendations include accelerating digital pathology adoption and creating a single diagnostic record across the NHS.

Guideline-Based Recommendations

Diagnosis

• Expand community diagnostics to improve patient access and reduce hospital pressures.

Management

• Implement self-collection methods for HPV to enhance screening efforts.

Monitoring & Follow-up

• Invest in digital infrastructure and workforce training for effective IVD utilization.

Risks

• Inconsistent adoption and fragmented procurement may delay patient access to diagnostics.

Patient & Prescribing Data

Individuals requiring diagnostic testing and screening.

Targeted treatment decisions can be made through rapid diagnostics.

Clinical Best Practices

• Utilize point-of-care testing to enhance diagnostic efficiency.
• Adopt AI technologies to prioritize urgent laboratory cases.

Related Resources & Content

• Royal College of Pathologists White Paper